Multiple Sclerosis Treatment

ZINCARE

M. Chomba

BTK Inhibitors in Multiple Sclerosis: Overview & Update on Phase 3 T…

University of Miami

S. Delgado

2024 Proposed Diagnostic Criteria for Multiple Sclerosis

University of Miami

N. Baldwin

The Role of B Cells in Progressive MS and the Long-term Effects of B…

The France Foundation

J. Berger

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

Multiple Sclerosis Year in Review 2024

UF Health Norman Fixel Institute for Neurological Diseases

T. Rempe

Multiple Sclerosis for the Non-Neurologist

Providence Swedish

J. D. Bowen

Aberrant Iron Deposition in the Progressive MS Spinal Cord Relates t…

Marco Pisa

Symptomatic Management in Multiple Sclerosis

ZINCARE

A. Simpson

ECTRIMS 2024 Insights: Pathology of NMOSD, MOGAD and MS

Hans Lassmann

The Connection Between Viruses and Other Factors Contributing to the…

The France Foundation

M. Levy

Neural effects of fatigue on cognition in relapsing MS detected by m…

2023 Conference Coverage

A. Memon

Breaking Down Common But Complicated Questions in MS: Updates on Bio…

Women Neurologists Group (WNG)

E. M. Schorr

ECTRIMS 2024 Insights: Role of Diet, Vitamins and in MS

Anneke Van Der Walt

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

Navigating Neurogenic Bladder and Sexual Dysfunction

Diagnosis and Management of Neurogenic Bladder and Sexual Dysfunction Video Series

T. Kaplan

COVID-19 Vaccination and Immunotherapies for Multiple Sclerosis

University of Miami

K. Rammohan

Highlights on Multiple Sclerosis: Topographical Model of MS and JC V…

2023 Conference Coverage

S. Krieger

ACOG Insights - Mind the Gap: Estrogen Receptor Beta in Astrocytes i…

Rhonda Voskuhl

MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacer…

Stephen Krieger